✦ LIBER ✦

Impact of diabetes and glycaemic control on peripheral artery disease in Japanese patients with end-stage renal disease: long-term follow-up study from the beginning of haemodialysis

✍ Scribed by H. Ishii; Y. Kumada; H. Takahashi; T. Toriyama; T. Aoyama; M. Tanaka; D. Yoshikawa; M. Hayashi; H. Kasuga; Y. Yasuda; S. Maruyama; T. Matsubara; S. Matsuo; T. Murohara

Book ID: 113017775
Publisher: Springer
Year: 2012
Tongue: English
Weight: 291 KB
Volume: 55
Category: Article
ISSN: 0012-186X
DOI: 10.1007/s00125-012-2473-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The impact of glycaemic control on outco

The impact of glycaemic control on outcomes in patients with end-stage renal disease and type 2 diabetes (Review Article)

✍ SOPHIA ZOUNGAS; PETER G KERR; MICHELLE LUI; HELENA J TEEDE 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

End-stage renal disease and dialysis in

End-stage renal disease and dialysis in HIV-positive patients: observations from a long-term cohort study with a follow-up of 22 years

✍ M Bickel; W Marben; C Betz; P Khaykin; C Stephan; P Gute; A Haberl; G Knecht; T 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

Systemic Lupus Erythematosus in Patients

Systemic Lupus Erythematosus in Patients with End-Stage Renal Disease: Long-Term Follow-Up on the Prognosis of Patients and the Evolution of Lupus Activity

✍ Cheigh, Jhoong S.; Kim, Hong; Stenzel, Kurt H.; Tapia, Luis; Sullivan, John F.; 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 753 KB

Impact on mortality and incidence of end

Impact on mortality and incidence of end-stage renal disease of education and treatment at a diabetes center among patients with type 1 diabetes: Comparison of two subgroups in the Japanese DERI cohort

✍ Yasuko Uchigata; Keiko Asao; Masato Matsushima; Akiko Sato; Hiroki Yokoyama; Tos 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 142 KB

P.4.044 Long-term efficacy of donepezil

P.4.044 Long-term efficacy of donepezil in patients with mild to moderate Alzheimer's disease: Results from a one-year placebo-controlled study and two-year follow-up study

✍ B. Winblad; A. Wimo; A.-L. Wetterholm; A. Haglund; K. Engedal; H. Soininen; F.R. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Time course, clinical pathways, and long

Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides : A multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas

✍ Pietro Quaglino; Nicola Pimpinelli; Emilio Berti; Piergiacomo Calzavara-Pinton; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB